United States Antimony (NYSE:UAMY) Shares Gap Down After Analyst Downgrade

United States Antimony Co. (NYSE:UAMY) gapped down prior to trading on Wednesday after HC Wainwright lowered their price target on the stock from $11.75 to $9.25. The stock had previously closed at $6.58, but opened at $5.44. HC Wainwright currently has a buy rating on the stock. United States Antimony shares last traded at $5.2660, with a volume of 5,102,278 shares changing hands.

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of United States Antimony in a research report on Wednesday, June 17th. Five research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $8.42.

Insider Activity

In other United States Antimony news, Director Jon R. Marinelli bought 12,500 shares of United States Antimony stock in a transaction dated Monday, June 15th. The stock was bought at an average cost of $7.45 per share, for a total transaction of $93,125.00. Following the purchase, the director owned 12,500 shares in the company, valued at $93,125. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 5.50% of the stock is currently owned by insiders.

Hedge Funds Weigh In On United States Antimony

Several hedge funds and other institutional investors have recently modified their holdings of UAMY. KBC Group NV bought a new position in United States Antimony in the 1st quarter worth about $31,000. Meeder Asset Management Inc. acquired a new stake in shares of United States Antimony in the fourth quarter valued at $35,000. Harbour Investments Inc. lifted its holdings in United States Antimony by 106.2% in the 4th quarter. Harbour Investments Inc. now owns 7,962 shares of the company’s stock valued at $40,000 after acquiring an additional 4,101 shares during the last quarter. Geneos Wealth Management Inc. boosted its holdings in United States Antimony by 17.9% during the first quarter. Geneos Wealth Management Inc. now owns 9,892 shares of the company’s stock worth $86,000 after buying an additional 1,500 shares in the last quarter. Finally, Focus Partners Wealth bought a new stake in shares of United States Antimony during the 3rd quarter worth $62,000. Institutional investors and hedge funds own 9.49% of the company’s stock.

United States Antimony Trading Down 20.7%

The stock has a 50-day moving average of $6.65 and a two-hundred day moving average of $8.32. The firm has a market cap of $772.81 million, a price-to-earnings ratio of -40.12 and a beta of 0.39.

United States Antimony Company Profile

United States Antimony Corporation is a specialized mining and chemical company focused primarily on the production and processing of antimony and antimony-based compounds. The company operates its own extraction and milling facilities to recover antimony metal and antimony trioxide, which serve as critical raw materials in industries such as flame retardants for plastics and textiles, catalysts for chemical processes, and additives for glass and ceramics. In addition to antimony, United States Antimony maintains smaller-scale gold and silver operations in Mexico that provide supplementary revenue streams and diversification of its mineral portfolio.

Founded in the mid-20th century, United States Antimony has evolved from a single‐mine operator into a multinational enterprise with mining and processing sites in both the United States and Mexico.